Cingulate begins Phase 3 tests of novel treatment for ADHD By: Kansas City Business Journal via Business Journals January 09, 2023 at 08:25 AM EST Cingulate's technology will let patients receive treatment ADHD treatment without second doses, boosters to get through the day. Read More >>
